Quinine conjugates and quinine analogues as potential antimalarial agents. Eur J Med Chem 2015 Jun 05;97:335-55
Date
02/17/2015Pubmed ID
25683799DOI
10.1016/j.ejmech.2015.02.002Scopus ID
2-s2.0-84937428911 (requires institutional sign-in at Scopus site) 79 CitationsAbstract
Malaria is a tropical disease, prevalent in Southeast Asia and Africa, resulting in over half a million deaths annually; efforts to develop new antimalarial agents are therefore particularly important. Quinine continues to play a role in the fight against malaria, but quinoline derivatives are more widely used. Drugs based on the quinoline scaffold include chloroquine and primaquine, which are able to act against the blood and liver stages of the parasite's life cycle. The purpose of this review is to discuss reported biologically active compounds based on either the quinine or quinoline scaffold that may have enhanced antimalarial activity. The review emphasises hybrid molecules, and covers advances made in the last five years. The review is divided into three sections: modifications to the quinine scaffold, modifications to aminoquinolines and finally metal-containing antimalarial compounds.
Author List
Jones RA, Panda SS, Hall CDAuthor
Rachel Jones Lipinski Research Scientist I in the Biochemistry department at Medical College of WisconsinMESH terms used to index this publication - Major topics in bold
AnimalsAntimalarials
Humans
Malaria
Quinine
